These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1335021)

  • 1. The molecular biology of poliovaccines.
    Minor PD
    J Gen Virol; 1992 Dec; 73 ( Pt 12)():3065-77. PubMed ID: 1335021
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic basis of attenuation of the Sabin oral poliovirus vaccines.
    Minor PD; Macadam AJ; Stone DM; Almond JW
    Biologicals; 1993 Dec; 21(4):357-63. PubMed ID: 8024751
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccines based on recombinant antigen strategies.
    Minor P
    Dev Biol (Basel); 2001; 105():189-94. PubMed ID: 11763327
    [No Abstract]   [Full Text] [Related]  

  • 4. An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain.
    Macadam AJ; Ferguson G; Arnold C; Minor PD
    J Virol; 1991 Oct; 65(10):5225-31. PubMed ID: 1654440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and accurate identification of poliovirus strains used for vaccine production.
    Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B
    J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses.
    Mattion NM; Reilly PA; DiMichele SJ; Crowley JC; Weeks-Levy C
    J Virol; 1994 Jun; 68(6):3925-33. PubMed ID: 8189529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, construction, and characterization of poliovirus antigen chimeras.
    Evans DJ; Almond JW
    Methods Enzymol; 1991; 203():386-400. PubMed ID: 1662331
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of two determinants that attenuate vaccine-related type 2 poliovirus.
    Ren RB; Moss EG; Racaniello VR
    J Virol; 1991 Mar; 65(3):1377-82. PubMed ID: 1847458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a consistent pattern of mutations in neurovirulent variants derived from the sabin vaccine strain of poliovirus type 2.
    Equestre M; Genovese D; Cavalieri F; Fiore L; Santoro R; Perez Bercoff R
    J Virol; 1991 May; 65(5):2707-10. PubMed ID: 1850043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses.
    Stanway G; Cann AJ; Hauptmann R; Mountford RC; Clarke LD; Reeve P; Minor PD; Schild GC; Almond JW
    Eur J Biochem; 1983 Oct; 135(3):529-33. PubMed ID: 6311539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3.
    Minor PD; Dunn G; Evans DM; Magrath DI; John A; Howlett J; Phillips A; Westrop G; Wareham K; Almond JW
    J Gen Virol; 1989 May; 70 ( Pt 5)():1117-23. PubMed ID: 2543771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Variability of poliomyelitis virus strains in nature and significance of this factor for the prevention of poliomyelitis].
    Gendon IuZ
    Vopr Virusol; 1988; 33(2):137-41. PubMed ID: 2457986
    [No Abstract]   [Full Text] [Related]  

  • 13. Inactivated vaccines based on alternatives to wild-type seed virus.
    Chumakov K; Dragunsky E; Ivshina A; Enterline J; Wells V; Nomura T; Gromeier M; Wimmer E
    Dev Biol (Basel); 2001; 105():171-7. PubMed ID: 11763325
    [No Abstract]   [Full Text] [Related]  

  • 14. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
    Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic, non-infectious polio subviral particles synthesized in Saccharomyces cerevisiae.
    Rombaut B; Jore JP
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1829-32. PubMed ID: 9266976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation and reversion of the Sabin vaccine strains of poliovirus.
    Minor PD
    Dev Biol Stand; 1993; 78():17-26. PubMed ID: 8388828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological and pathogenic properties of poliovirus variants selected for resistance to antiviral drug V-073.
    Kouiavskaia DV; Dragunsky EM; Liu HM; Oberste MS; Collett MS; Chumakov KM
    Antivir Ther; 2011; 16(7):999-1004. PubMed ID: 22024515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus.
    Georgescu MM; Delpeyroux F; Crainic R
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2343-8. PubMed ID: 7561775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poliovirus type 3/Saukett: antigenic and structural correlates of sequence variation in the capsid proteins.
    Huovilainen A; Kinnunen L; Pöyry T; Laaksonen L; Roivainen M; Hovi T
    Virology; 1994 Feb; 199(1):228-32. PubMed ID: 8116248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic hybrids of poliovirus.
    Hogle JM
    Nature; 1988 Mar; 332(6159):13-4. PubMed ID: 2831454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.